One form of vitamin E appears beneficial in reducing bladder cancer risk

March 30, 2004

ORLANDO -- One form of vitamin E appears to offer protection against development of bladder cancer, while a second form has no beneficial effect, say a team of researchers led by The University of Texas M. D. Anderson Cancer Center. These findings were presented at the annual meeting of the American Association for Cancer Research.

In a five-year study, which included 468 newly diagnosed bladder cancer patients and 534 cancer-free controls, the researchers found that high dietary intake of alpha-tocopherol, one form of vitamin E, significantly reduced the risk of developing bladder cancer.

But gamma-tocopherol, which is consumed in greater amounts than alpha-tocopherol in the United States, offered no protection, say the researchers, led by Xifeng Wu, M.D., Ph.D., associate professor in the Department of Epidemiology at M. D. Anderson, and including nutritionists from Texas Woman's University as well as epidemiologists from M. D. Anderson.

"High intake of vitamin E from dietary sources was associated with a 42 percent reduced risk of bladder cancer whereas a high intake of vitamin E from diet and supplements combined reduced the risk by 44 percent," says the study's first author, research dietician Ladia Hernandez, M.S., R.D. L.D., research dietitian in the Department of Epidemiology at M. D. Anderson.

"The study is not over, but my advice is that everyone should eat a healthy diet that includes fruit, vegetables and nuts," says co-investigator, John Radcliffe, Ph.D., R.D., of the Department of Nutrition and Food Sciences at Texas Woman's University. "Most people now do not meet the recommended dietary allowance of 15 milligrams of vitamin E from their diet; typical dietary intake is 8 milligrams per day."

Many vegetables, nuts, fruits and oils contain both forms of vitamin E, but those richest in alpha-tocopherol include almonds, red and green peppers, spinach, mustard greens, sunflower seeds and vegetable oils, including cottonseed and safflower oils, say the researchers based on their extensive food analysis. Those high in gamma-tocopherol include walnuts, pecans, garbanzo beans and soybean oil.

Previous research tentatively linked low intake of vitamin E to bladder cancer, but those studies did not distinguish between the different forms of vitamin E, which include four tocopherols. Only the alpha and gamma forms of tocopherol are predominate in food, and because they are metabolized differently, a recent Institute of Medicine report suggested they should be studied separately.

To do that meant that Radcliffe and Hernandez developed a database for the alpha- and gamma-tocopherol contents of 200 different foods, based on an extensive review of published values and their own analytical values for foods like cornbread and french fries. These values were used to estimate the intakes of the two tocopherols in an ongoing case-control study.

Participants answered a detailed food-frequency questionnaire that summed up their dietary habits the year before they were diagnosed with the bladder cancer or, in the cancer-free control group, the year before they agreed to participate in the study. The researchers then factored out other known risks for developing bladder cancer, such as smoking, age, ethnicity and gender, to determine the benefits of the two forms of vitamin E.

"Our long term goal is to identify risk factors that are important for bladder cancer development," says Wu.

Radcliffe says more studies are suggesting that different vitamins protect against different forms of cancer, and some point to a benefit from gamma-tocopherol in reducing the risk of developing prostate cancer. "There are theories as to how these vitamins work to protect against disease, but we need more research to elucidate the details of the mechanisms involved."
-end-


University of Texas M. D. Anderson Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.